Glucose– tag –
-
Beyond Glucose: Advancements in Wearable and Implantable Biosensors Enable Continuous Monitoring of Metabolic, Hormonal, and Inflammatory Biomarkers
Frontiers Switzerland Overview This review states that wearable and implantable biosensors are shifting biochemical evaluation from episodic testing to continuous physiological monitoring of metabolic, hormonal, and inflammatory biomarke... -
Elastic Substrates and Nanomaterials Enable Seamless Bio-Interfaces: Wearable and Implantable Sensors Revolutionize Continuous Physiological Monitoring
ResearchGate Germany Overview Advances in skin-attachable and implantable sensor technologies are dramatically transforming continuous physiological monitoring, driven by innovative interface architectures like elastic substrates, functi... -
City of Hope Initiates Clinical Trial for Wearable Biosensor Patch to Non-Invasively Monitor Oxygen, CO, Glucose, and Inflammatory Markers Perioperatively
ClinicalTrials.gov (via Power.com) USA Overview City of Hope Medical Center has launched a clinical trial (NCT07612085) to evaluate the feasibility and safety of a wearable biosensor patch for non-invasive, real-time monitoring of oxygen... -
Wearable and Implantable Biosensors Advance Beyond Glucose to Continuous Monitoring of Metabolic, Hormonal, and Inflammatory Biomarkers
Frontiers in Bioengineering and Biotechnology Switzerland Overview Wearable and implantable biosensors are undergoing a paradigm shift, moving beyond continuous glucose monitoring to encompass comprehensive real-time tracking of diverse ... -
Next-Generation Bionic Sensors Integrating Synthetic Biology, Nanomaterials, and AI Revolutionize Precision Medicine and Real-Time Monitoring
MDPI Switzerland Overview Next-generation bionic sensors, integrating synthetic biology, nanomaterials, and artificial intelligence (AI), are poised to revolutionize precision medicine and real-time biomarker monitoring. These wearable a... -
FDA Clears Dexcom Stelo Glucose Biosensor as First Over-the-Counter CGM for Insulin-Naive Children Aged 2 and Up
U.S. Food and Drug Administration (FDA) USA Overview The U.S. FDA has granted the first over-the-counter (OTC) clearance for Dexcom's Stelo Glucose Biosensor System, expanding its use to insulin-naive children aged two and older. This la... -
Real-Time Fermentation Monitoring Achieved with Raman Spectroscopy-Based PAT in Food, Beverage & Industrial Bioprocessing
Technology Networks Global Overview Process Analytical Technology (PAT) tools, particularly Raman and Near-Infrared (NIR) spectroscopy, are extending their application from biopharma bioreactors to industrial fermentation for real-time m... -
Dexcom Stelo Secures First FDA OTC CGM Approval, Abbott Advances Freestyle Libre 3 Plus with 15-Day Wear & AID Compatibility
CNET USA Overview Dexcom's Stelo achieved the first FDA approval for an over-the-counter Continuous Glucose Monitor (CGM) in 2024, significantly broadening access for general consumers. Concurrently, Abbott's Freestyle Libre 3 Plus enter... -
Affordable Sensor Innovations Democratize Neuroscience: Electrochemical and Optical Biosensors Drive Personalized Healthcare
JATIR (Journal of Academic Trends & Innovative Research) International Overview This article explores innovations in affordable sensor technologies within neuroscience and broader biomedical applications, contributing to personalized hea... -
ALR Technologies to Acquire CGM Medical Shenzhen, Boosting CGM Manufacturing Capacity to 300,000 Units Monthly by January 2027
ALR Technologies (Press Release) USA Overview ALR Technologies announced plans to acquire CGM Medical Shenzhen to enhance its development of accurate and affordable continuous glucose monitor (CGM) devices for diabetes management. This a...
